German WPC specialist Naturinform engages experienced export director and manager
11.2.2025 10:13:49 CET | news aktuell GmbH | Press release
Redwitz a.d. Rodach
German WPC (Wood-Polymer-Composite) specialist Naturinform increases its international business and further expands its market presence. By engaging Edward Robinson as the Director of International Business Development, the enterprise relies on an experienced industry specialist in order to strategically advance its export business even more. A native of England, Robinson boasts with nearly 20 years of experience in the European composites industry, recently holding the same leading position at UPM-Profi.
"Our sustainable wood composite material profiles have become increasingly popular around the globe. The great interest international visitors showed to our products at the world's leading trade fair BAU in January confirms that our opportunities in the global market are substantial. With Edward Robinson, we won over a proven expert who will support us in our efforts to further expand our export activities", says Horst Walther, Managing Partner of Naturinform.
In addition to that, Yves Houbrechts joined Edward Robinson's team as the Sales Manager for the Netherlands and Belgium region. Houbrechts also has profound experience in the composite materials market and will make significant contributions to strengthen Naturinform's presence in these markets.
According to Horst Walther, this internationalisation is a key strategy for future growth of the enterprise: "By integrating UPM products and expanding our own product series for co-extruded decking boards, we are laying the groundwork for permanently consolidating our position in the international market and opening up new business opportunities."
Managing Director Pia Hobeck underlines the importance of innovation, product diversity and sustainability for their corporate strategy: "As a leading provider of WPC solutions with environment-friendly and versatile products, we will remain true to our strategy of inspiring even foreign markets and thus successfully growing in the long run."
Presscontact:
PR I KOMMUNIKATION
info@heinrich-renz.de
Images
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
FEV collaborates with Microsoft on efficient AI model approach for in car applications built on NVIDIA9.7.2026 11:05:00 CEST | Press release
Aachen – FEV is collaborating with Microsoft to integrate powerful, in-vehicle Generative AI capabilities built on NVIDIA GPU-accelerated compute and AI model microservices. The cooperation aims to enable multimodal voice, text, and gesture interactions directly in the vehicle – independent of a permanent Internet connection.
Acrobat Studio og Acrobat KI-assistent: den nye generasjonen KI-støttet produktivitet – nå også på norsk8.7.2026 15:08:48 CEST | Press release
SAN JOSE, Calif. - 8. juli 2026 - Adobe utvider tilgjengeligheten til Acrobat Studio og Acrobat KI-assistenten i Norge. Nå er de KI-støttede funksjonene for produktivitet og kreavtivitet også tilgjengelige på norsk, og kan dermed brukes av brukere på lokalt språk. Acrobat Studio kombinerer Adobe Acrobat Pro, Adobe Express Premium og smarte KI-assistenter. Acrobat KI-assistent er også tilgjengelig som et separat tillegg for alle Adobe Acrobat-produkter (Acrobat Reader, Acrobat Standard og Acrobat Pro) – et fleksibelt alternativ for alle som ønsker å bruke KI-støttede funksjoner kun når de arbeider med dokumenter. Begge disse tilbudene gjør det mulig for brukere å raskere samle inn informasjon i PDF-er og Office-dokumenter, opprette innhold og effektivisere arbeidsflyten. Acrobat Studio og Acrobat KI-assistenten markerer et viktig trinn i utviklingen av PDF-filen, som har blitt standarden for viktige dokumenter siden den ble lansert av Adobe i 1993. Acrobat utvikler seg fra et ledende pr
Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy8.7.2026 10:37:04 CEST | Press release
Aachen, 08 July 2026 – Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD).
Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist29.6.2026 12:28:23 CEST | Press release
The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy option for the treatment of acute and chronic pain. In a Phase I trial, the investigational compound was demonstrated to be safe and well tolerated. A Phase II trial will commence later this year.
FRITZ: YouGov survey in 14 countries: Trust in router manufacturers from different regions European consumers mistrust Chinese routers29.6.2026 10:00:00 CEST | Press release
More than half of consumers in Norway mistrust routers from Chinese manufacturers (59%) Many mistrust devices made in the USA European routers enjoy a high level of trust across Europe (60%) For half of Europeans (55%), the ‘Made in Europe’ label important to when making a purchase
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom